Home/Helicore Biopharma/Paul Kierstead, PhD
PK

Paul Kierstead, PhD

Vice President, Drug Substance

Helicore Biopharma

Therapeutic Areas

Helicore Biopharma Pipeline

DrugIndicationPhase
GIP-neutralizing antibodyObesityPre-clinical